Center-Authored Papers

Filters: Author is Bredeson, Christopher  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
*Whole-Body Irradiation
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
2008
Rezvani AR, Norasetthada L, Gooley TA, Sorror ML, Bouvier ME, Sahebi F, Agura E, Chauncey TR, Maziarz RT, Maris M et al..  2008.  Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.. British journal of haematology. 143(3):395-403. Abstract
2009
Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C et al..  2009.  Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(12):1543-54. Abstract
Ringdén O, Pavletic SZ, Anasetti C, Barrett JA, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C et al..  2009.  The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.. Blood. 113(13):3110-8. Abstract
2012
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
2013
Bredeson C, Le Rademacher J, Kato K, Dipersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn MR, Laport GG, Zhu X et al..  2013.  Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.. Blood. Abstract
Hahn T, McCarthy PL, Hassebroek A, Bredeson C, Gajewski JL, Hale GA, Isola LM, Lazarus HM, Lee SJ, LeMaistre CF et al..  2013.  Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(19):2437-49. Abstract
Majhail NS, Tao L, Bredeson C, Davies S, Dehn J, Gajewski JL, Hahn T, Jakubowski A, Joffe S, Lazarus HM et al..  2013.  Prevalence of Hematopoietic Cell Transplant Survivors in the United States.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
McCarthy PL, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale G, Isola L, Lazarus HM, Lee SJ, LeMaistre CF et al..  2013.  Trends in utilization and survival after autologous hematopoietic cell transplantation in North America from 1995 to 2005: Significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Acute Disease
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
Rezvani AR, Norasetthada L, Gooley TA, Sorror ML, Bouvier ME, Sahebi F, Agura E, Chauncey TR, Maziarz RT, Maris M et al..  2008.  Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.. British journal of haematology. 143(3):395-403. Abstract
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Acute Disease Adolescent Adult Aged Child
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
Adolescent
Ringdén O, Pavletic SZ, Anasetti C, Barrett JA, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C et al..  2009.  The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.. Blood. 113(13):3110-8. Abstract
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C et al..  2009.  Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(12):1543-54. Abstract
Rezvani AR, Norasetthada L, Gooley TA, Sorror ML, Bouvier ME, Sahebi F, Agura E, Chauncey TR, Maziarz RT, Maris M et al..  2008.  Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.. British journal of haematology. 143(3):395-403. Abstract
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
Adult
Rezvani AR, Norasetthada L, Gooley TA, Sorror ML, Bouvier ME, Sahebi F, Agura E, Chauncey TR, Maziarz RT, Maris M et al..  2008.  Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.. British journal of haematology. 143(3):395-403. Abstract
Sorror ML, Maris MB, Sandmaier BM, Storer BE, Stuart MJ, Hegenbart U, Agura E, Chauncey TR, Leis J, Pulsipher M et al..  2005.  Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(16):3819-29. Abstract
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Ringdén O, Pavletic SZ, Anasetti C, Barrett JA, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C et al..  2009.  The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.. Blood. 113(13):3110-8. Abstract
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S et al..  2012.  Peripheral-blood stem cells versus bone marrow from unrelated donors.. The New England journal of medicine. 367(16):1487-96. Abstract